Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
Junsha An, Cheng Peng, Hailin Tang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9644-9644
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Françoise Derouane, Cédric van Marcke, Martine Berlière, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3876-3876
Open Access | Times Cited: 43
Molecular Research and Treatment of Breast Cancer
Anna Kawiak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9617-9617
Open Access | Times Cited: 27
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
Wenjie Xia, Wuzhen Chen, Chao Ni, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 18
Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance
Aliye Tabatabaee, Behjat Nafari, Armin Farhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 363-377
Closed Access | Times Cited: 16
Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy
Jinhui Zhang, Huajie Guan, Cailu Song, et al.
Chinese Medical Journal (2025)
Open Access
Chelidonine overcomes P-gp-mediated adriamycin resistance in MCF-7/ADR cells by inhibiting PDGFRβ/PI3K/Akt pathway
Xiang Zou, Yuhang Zhang, Kai‐Li Liu, et al.
Chinese Herbal Medicines (2025)
Open Access
Virtual Screening of Gum Arabic Compounds for Breast Cancer-Related Receptors: Target Selection and Therapeutic Potential
Ahmed A. M. Elnour, Ashraf Nour, Yasser S. Ahmed, et al.
(2025), pp. 307-336
Closed Access
The effect of the combination therapy with chlorophyllin, a glutathione transferase P1-1 inhibitor, and docetaxel on triple-negative breast cancer invasion and metastasis in vivo/in vitro
Ayşe Buruş, Mehmet Özcan, Hande Canpınar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Dehydrodiisoeugenol targets the PLK1-p53 axis to inhibit breast cancer cell cycle
Dan Li, Yifan Zheng, Yongxia Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Piperlongumine induces ROS accumulation to reverse resistance of 5-FU in human colorectal cancer via targeting TrxR
Ji Zhou, Qing Shu, Tian Wang, et al.
European Journal of Pharmacology (2025), pp. 177478-177478
Closed Access
Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
Fu Peng, Li Wang, Liang Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis
Xiang Song, Xinzhao Wang, Xiqi Chen, et al.
Journal of Proteomics (2023) Vol. 292, pp. 105055-105055
Closed Access | Times Cited: 12
Regulation of Ca2+ for Cancer Cell Apoptosis through Photothermal Conjugated Nanoparticles
Mei Zhou, Boying Li, Ning Li, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 2834-2842
Closed Access | Times Cited: 18
Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report
Letizia Cuniolo, Marco Gipponi, Federica Murelli, et al.
Current Oncology (2024) Vol. 31, Iss. 5, pp. 2856-2866
Open Access | Times Cited: 3
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities—A State-of-the-Art Review
Dominika Kunachowicz, Karolina Kłosowska, N. Sobczak, et al.
Nanomaterials (2024) Vol. 14, Iss. 17, pp. 1424-1424
Open Access | Times Cited: 3
New Advances in Targeted Therapy of HER2-Negative Breast Cancer
Junsha An, Cheng Peng, Xiaofang Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
Xiaolu Sun, Kuai Liu, Shuli Lu, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5456-5456
Open Access | Times Cited: 16
Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis
Ruiliang Chen, Yushuai Yu, Jie Zhang, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 7, pp. 599-611
Closed Access | Times Cited: 2
Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer
Alex Silva, Marcella R. Cardoso, Danilo Cardoso de Oliveira, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2473-2473
Open Access | Times Cited: 2
Nanomaterials: breaking the bottleneck of breast cancer drug resistance
Chao Guan, Yanbing Han, Ling Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects
Xingjia Lu, Jian Zhong, Linlin Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
Wenna Shao, Xinzhao Wang, Zhaoyun Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy
Ru Wang, Nuannuan Li, Tianyu Zhang, et al.
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
Hailing Zhang, Xiaodi Yan, Hongmei Gu, et al.
Journal of Thoracic Disease (2022) Vol. 14, Iss. 12, pp. 4785-4802
Open Access | Times Cited: 10
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer
Om Elez Bouhniz, Abderraouf Kénani
Journal of Chemotherapy (2024), pp. 1-15
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top